Concepedia

Nadia Godin-Heymann

NG

8

Publications

2.1K

Citations

8

H-Index

2005

Active since

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Ludwig Cancer Research

Center for Cancer Research

University of Oxford

Nadia Godin-Heymann is an author at Massachusetts General Hospital specializing in cancer research, medicine, and oncology.

Top concepts

Publications per year

2005–2015

8

Publications

8

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

Eunice L. Kwak, Raffaella Sordella, Daphne W. Bell et al. · Proceedings of the National Academy of Sciences · 2005 · 951 citations · Full text

Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR

Daphne W. Bell, Ira Gore, Ross A. Okimoto et al. · Nature Genetics · 2005 · 528 citations

, , +9

The T790M “gatekeeper” mutation in <i>EGFR</i> mediates resistance to low concentrations of an irreversible EGFR inhibitor

Nadia Godin-Heymann, Lindsey Ulkus, Brian W. Brannigan et al. · Molecular Cancer Therapeutics · 2008 · 204 citations · Full text

<i>HOXB9</i>, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis

Tetsu Hayashida, Fumiyuki Takahashi, Naokazu Chiba et al. · Proceedings of the National Academy of Sciences · 2009 · 156 citations · Full text

Oncogenic Activity of Epidermal Growth Factor Receptor Kinase Mutant Alleles Is Enhanced by the T790M Drug Resistance Mutation

Nadia Godin-Heymann, Ianthe Bryant, Miguel N. Rivera et al. · Cancer Research · 2007 · 151 citations · Full text

Rows per page

1–5 of 8